TrialWire Patient Recruitment Platform that Reboots Stalled Clinical Trials announced as Multi-Award Finalist in the 2024 Citeline Awards
2024年5月13日 - 5:29AM
TrialWire Patient Recruitment Platform that Reboots Stalled
Clinical Trials announced as Multi-Award Finalist in the 2024
Citeline Awards
The TrialWire™ Rapid Patient Recruitment Platform, the only
pay-per-enrolled fixed-fee solution powered by AI and algorithms,
has been selected as a finalist by Citeline in three key
categories:
- Best use of artificial intelligence in clinical
trials
- Best patient-facing technology initiative
- Best sponsor-facing technology initiative
Try pay-per-enrollment starts in 24 hours
TrialWire™ not only finds highly eligible patients on time but
also reduces patient communication delays and friction, cutting the
contact and screening time at the sites. In a typical study, up to
50% of patients can be lost due to contact failure. The TrialWire™
Unified Communications System and real-time alerts and escalations
solves this problem and rapidly reboots trials. Sponsors and CROs
can see real time progress and are alerted if any patient contact
is not progressed.
Susan Fitzpatrick-Napier, CEO and Founder of TrialWire™, thanked
clients and key technology partners for their role in the success
of the TrialWire™ Platform, which is being harnessed by biopharma
for both site-based and DCT studies.
“We’re very pleased to build on the 2023 Citeline Award
win and again be recognised as a key industry player in the
clinical trial space. We want to thank our CRO and biopharma
clients across the globe and our world-leading technology partners
including Salesforce Health Cloud, Uber Health, and Twilio that
enable us to deliver the most advanced secure, efficient, and
trusted services for our clients.
“To be recognized across these 3 categories - as a leader
in patient recruitment AI and technology, and excellence in
patient and sponsor engagement - is exceptional. It highlights our
collective ambition to deliver an innovative, patient-centric, and
diversity- and accessibility-focused platform.”
According to Citeline, these awards “showcase excellence in
clinical trial design, technological advancements, and results as
well as the outstanding achievements of individuals, departments,
teams or organisations.”
The award categories and finalists are as follows:
Best Use of Artificial Intelligence in Clinical
TrialsAI is transforming healthcare, gaining ground in
Pharma. It offers novel avenues to enhance drug discovery, clinical
development, and new drug adoption. This Award honours those
leveraging AI to streamline clinical trial processes or ensure
their success.
FINALISTS ARE:
- ICON
- Medidata
- Moderna
- TrialWire
- Yseop
Best Patient-facing Technology InitiativeThis
Award celebrates the transformative impact of digital health tech
in clinical trials. Innovators are reshaping patient data
collection with diverse digital tools like smartphone apps and
mobile health devices. Judges are seeking products elevating
patient experience and data quality, from electronic diaries to
innovative mobile devices, fostering seamless trial
participation.
FINALISTS ARE:
- IQVIA
- Medidata’s eCOA - Medidata, a Dassault Systèmes Company
- Moderna and ProofPilot
- TrialWire
Best Sponsor-facing Technology
Initiative This Award acknowledges the crucial role
of cutting-edge platforms in maximising clinical trial data.
Advanced software drives efficiency across trial stages, aiding
sponsors in logistics, monitoring, risk mitigation, and data
analysis. Judges seek products enhancing study team management and
oversight of trial activities.
FINALISTS ARE:
- Bioforum, The Data Masters
- Certara
- CluePoints
- Cytel
- Medidata: The Medidata Clinical Data Studio Team
- Phastar
- TrialWire
With more than 80% of clinical trials failing to recruit
patients on time, and 30% of research sites not able to meet
enrollment goals (10% of sites don’t enroll any patients),
TrialWire™ offers peace of mind and significant cost and
time-saving for sites, sponsors, CROs, and investors.
TrialWire™ auto recruitment can start and scale quickly, in
under 24 hours, as the platform does not require any approvals to
begin.
The TrialWire™ Platform built on the secure Salesforce Health
Cloud includes:
- Dedicated secure portal dashboards for each study coordinator
(SC) so they can review patient details and medical information and
see real-time progress
- Dashboards for sponsors and CROs so they can
view real-time de-identified referral status data
- Secure Unified Communications System including text, video
(telehealth), emails, and phone for SCs within their dashboard for
instant communication with patients to book calls, screen and
arrange site visits
- Automated AI-match and algorithm-driven find, screen and enroll
system
- Minute-by-minute metrics for SCs, sponsors and CROs
showing the number of patients referred, contacted, screened,
and enrolled at each site
- Study progress data download for sponsors and CROs
- HIPAA compliance and patient privacy security
- Unlimited number of sites globally
- Available in all languages
- ScreenMatch – the “white glove” SC support system that
helps contact and phone screen patients
- Uber Health for patient transport bookings
About TrialWire™
www.trial-wire.comTrialWire™ is a privately held
technology company that leverages 25 years of experience in the
clinical trial patient recruitment sector.
TrialWire™ is solving the patient recruitment crisis which is
one of the most serious problems facing the drug development
sector, costing billions of dollars a day due to stalled
trials.
The TrialWire™ Platform is the most secure service (powered by
Salesforce Health Cloud) that uses AI and advanced algorithms to
find the right people who are online researching their condition.
It uses all available online information including demographics,
intent and content to determine eligibility.
Patients are invited into the Platform and taken through the
AI-Match screener then offered an exact study match. No account
sign-up is required. The Platform ingests study data from
approved trial registries like ClinicalTrials.Gov.
Key to the TrialWire™ success is that the platform looks for
motivated people who are active online trying to find out more
about their conditions. They can be connected to a site in under
two minutes. These people have consistently high retention
rates.